Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs
The Department of Labor finalized a rule that seeks to bring more transparency into PBM…
The Department of Labor finalized a rule that seeks to bring more transparency into PBM compensation. The post Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs appeared first on MedCity News.
Beginning January 1, 2027, the 2025 reconciliation law will limit immigrant eligibility for ACA Marketplace subsidies. This brief provides an overview of implementation of the immigrant eligibility changes for Marketplace subsidies and issues to consider for affected individuals and states.
The ACA Marketplace Open Enrollment season begins November 1, bringing higher out-of-pocket premium payments, new eligibility requirements for certain groups, and state efforts to offset premium increases following the expiration of enhanced premium tax credits. Read our analysis of what these and other changes could mean for enrollees.
Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently available monoclonal antibodies. Aspen Neuroscience also debuted on the Nasdaq as it prepares for a pivotal test of its Parkinson’s disease cell therapy. The post Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’ appeared first on…
CEO Caroline Zhang says that after winning an AI tech sprint, Knowtex is already in 310 clinics and 79 hospitals in the VA
For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ensure continued compliance. The post It’s A TRAP! Employer Concerns for Tuition Reimbursement and Other Employee Repayment Agreements appeared first on MedCity News.
CMS asked the right questions – the ones that will determine whether any future benefit actually reaches these patients. The post A Meaningful Signal on Palliative Care – But Not Yet a Benefit appeared first on MedCity News.
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec….
When Ashley Porter began slurring her speech one October day four years ago, doctors suspected a stroke. A spinal tap, an MRI, dozens of blood draws, another MRI, and a night spent at the hospital were followed, finally, by an answer: Porter had multiple sclerosis. Her shock turned to outrage, she said, when she received…
Chris McQueen finished treatment for leukemia a year and a half ago, but the ads for fake cures never stopped. Juice cleanses to cure cancer, “natural” cancer treatments, clinics in Mexico promising full recovery with little chemotherapy — all appeared on McQueen’s mobile phone during routine oncologist visits and monthly bloodwork. McQueen and others have…